WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 17 fonti

Experimental pill promises new hope for deadly pancreatic cancer

New research shows a novel pill is helping people with advanced pancreatic cancer live longer

Raccontata da

biopharmadive.com

medpagetoday.com

independent.co.uk

theguardian.com

cnn.com+5 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

independent.co.ukStai leggendo1 g fa

Experimental pill promises new hope for deadly pancreatic cancer

New research shows a novel pill is helping people with advanced pancreatic cancer live longer

Timeline cronologica

sabato 30 maggio 2026·pbs.org
Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
domenica 31 maggio 2026·biopharmadive.com
‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer
Highly anticipated data presented at ASCO confirmed what’s been heralded as a medical breakthrough against a historically tough-to-treat tumor.

1 g fa

Experimental pill promises new hope for deadly pancreatic cancer | CNN

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.

Leggi questa versione → originale

dailysabah.com1 g fa

Experimental pill offers breakthrough hope in pancreatic cancer fight

Daraxonrasib, a daily oral KRAS inhibitor by Revolution Medicines, nearly doubled median survival in metastatic pancreatic cancer (13.2 vs 6.7 months) in a 500-patient Phase 3 trial, with the FDA fast-tracking review. The drug breaks a decades-long stalemate on KRAS — mutated in 90%+ of pancreatic cases — signaling that the "undruggable" oncology target class is now open, with downstream implications for RAS-driven cancers beyond pancreatic.

Leggi questa versione → originale

fortune.com1 g fa

Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually…

The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.

Leggi questa versione → originale

sciencealert.com1 g fa

Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers

WASHINGTON (AP) – A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.

Leggi questa versione → originale

inews.co.uk1 g fa

Why this new pill for a deadly cancer has doctors excited

The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer

Leggi questa versione → originale

domenica 31 maggio 2026·

medpagetoday.com

'Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

RASolute 302 findings herald a new standard of care in previously treated patients

domenica 31 maggio 2026·

nbcnews.com

After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

domenica 31 maggio 2026·

independent.co.uk

Daily pill almost doubles survival time for pancreatic cancer patients in new trial

Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

domenica 31 maggio 2026·

theguardian.com

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

domenica 31 maggio 2026·

dailymail.com

New drug gives extra months of life to pancreatic cancer patients

Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug was shown to give patients precious extra months of life.

domenica 31 maggio 2026·

independent.co.uk

Experimental pill promises new hope for deadly pancreatic cancer

New research shows a novel pill is helping people with advanced pancreatic cancer live longer

domenica 31 maggio 2026·

mirror.co.uk

Cancer breakthrough as new 'game-changing' pill could double survival time

Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that

domenica 31 maggio 2026·

independent.co.uk

Pancreatic cancer breakthrough as pill almost doubles survival time for patients

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

domenica 31 maggio 2026·

elnuevodia.com

“Es un gran paso”: píldora experimental promete nueva esperanza contra el mortal cáncer de páncreas

¿Cómo funciona? Esto es lo que dice un estudio

domenica 31 maggio 2026·

cbsnews.com

New drug nearly doubles survival rates in some pancreatic cancer patients, study says

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

domenica 31 maggio 2026·

fortune.com

Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune

The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…

domenica 31 maggio 2026·

cnn.com

Experimental pill promises new hope for deadly pancreatic cancer | CNN

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

domenica 31 maggio 2026·

dailysabah.com

Experimental pill offers breakthrough hope in pancreatic cancer fight

An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...

domenica 31 maggio 2026·

inews.co.uk

Why this new pill for a deadly cancer has doctors excited

The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer

domenica 31 maggio 2026·

quotidianodelsud.it

Cancro al pancreas, un nuovo farmaco raddoppia il periodo di sopravvivenza: lo studio - Il Quotidiano del Sud

2 minuti per la lettura (Adnkronos) – Una pillola, presa ogni giorno, può raddoppiare il periodo di sopravvivenza per i pazienti colpiti da cancro al pancreas. Sono i risultati di…

domenica 31 maggio 2026·

pbs.org

Experimental drug shows promise against deadly pancreatic cancer

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

lunedì 1 giugno 2026·

nature.com

Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments

Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumours will be next.

lunedì 1 giugno 2026·

sciencealert.com

Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers

WASHINGTON (AP) – A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of…